Evidence map›Paper›PMID 41498323›Full record

ReviewIndian journal of ophthalmology2026

IgG4-related orbital disease - An update.

Rachna Meel, Manu Saini, Hage Angku, Neelam Pushker, Sahil Agrawal, Seema Kashyap, Seema Sen

Abstract readReview
In one paragraph

Review in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rachna MeelDepartment of Oculoplasty and Ocular Oncology Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Manu SainiDepartment of Oculoplasty and Ocular Oncology Services, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Hage AngkuDepartment of Oculoplasty and Ocular Oncology Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Neelam PushkerDepartment of Oculoplasty and Ocular Oncology Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Sahil AgrawalDepartment of Oculoplasty and Ocular Oncology Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Seema KashyapDepartment of Ocular Pathology, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Seema SenDepartment of Ocular Pathology, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS) New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related orbital disease is an emerging systemic fibroinflammatory disease that has gained considerable recognition in the past 2 decades. The varied location and presentation of this indolent disease may often result in a diagnostic dilemma for clinicians. Early recognition, comprehensive systemic evaluation, and multidisciplinary approaches are essential for its management. Delayed diagnosis can cause irreversible organ damage, and this disease has shown to be associated with an increased risk of death. This article provides an update on the ophthalmic disease presentation, diagnostic criteria, and management.

Indexed as

Immunoglobulin GImmunoglobulin G4-Related DiseaseOrbital DiseasesDiagnosis, DifferentialHumansImmunoglobulin GIgG4-related diseaseIgG4-related orbital diseaseserum IgG4

Identifiers

PMID41498323
PMCPMC13614751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.